The measurement and application of thrombin generation

被引:132
作者
Baglin, T [1 ]
机构
[1] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 2QQ, England
关键词
thrombin; thrombin generation; thrombin potential; endogenous thrombin potential (ETP); thrombography; calibrated automated thrombography (CAT); coagulation phenotype;
D O I
10.1111/j.1365-2141.2005.05612.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is the capacity to generate thrombin, and the enzymatic work that thrombin does, that determines blood coagulability. Therefore, measurement of the enzymatic work potential of thrombin provides a method for quantifying the composite effect of the multiple factors that determine coagulation capacity. The application of measurement of thrombin generation to clinical decision making has been hampered by numerous technical difficulties and pitfalls, many of which have now been overcome. Technical advances now permit rapid, reproducible measurement. A review of clinical studies performed to date indicates the need to appreciate the precise methodology used in each case and the need to consider standardisation in future studies. Applying thrombin generation measurement to clinical decision making will require up-to-date estimates of risks relating to the disorder and the intended therapeutic intervention. Ultimately management studies will be required if the clinical utility of measurement of thrombin generation is to be proven.
引用
收藏
页码:653 / 661
页数:9
相关论文
共 67 条
  • [1] The ability of three global plasma assays to recognize thrombophilia
    Andresen, MS
    Abildgaard, U
    Liestol, S
    Sandset, PM
    Mowinckel, MC
    Odegaard, OR
    Larsen, ML
    Diep, LM
    [J]. THROMBOSIS RESEARCH, 2004, 113 (06) : 411 - 417
  • [2] Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study
    Baglin, T
    Luddington, R
    Brown, K
    Baglin, C
    [J]. LANCET, 2003, 362 (9383) : 523 - 526
  • [3] Rebuttal: Is a nihilistic approach to thrombophilia screening justified?
    Baglin, T
    Greaves, M
    [J]. THROMBOSIS AND HAEMOSTASIS, 2002, 88 (04) : 700 - 701
  • [4] BEGUIN S, 1989, THROMB HAEMOSTASIS, V61, P25
  • [5] Fibrin polymerization is crucial for thrombin generation in platelet-rich plasma in a VWF-GPIb-dependent process, defective in Bernard-Soulier syndrome
    Béguin, S
    Keularts, I
    Al Dieri, R
    Bellucci, S
    Caen, J
    Hemker, HC
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (01) : 170 - 176
  • [6] Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor
    Béguin, S
    Kumar, R
    Keularts, I
    Seligsohn, U
    Coller, BS
    Hemker, HC
    [J]. BLOOD, 1999, 93 (02) : 564 - 570
  • [7] PLATELET PROCOAGULANT ACTIVITY - PHYSIOLOGICAL SIGNIFICANCE AND MECHANISMS OF EXPOSURE
    BEVERS, EM
    COMFURIUS, P
    ZWAAL, RFA
    [J]. BLOOD REVIEWS, 1991, 5 (03) : 146 - 154
  • [8] ASSESSMENT OF HYPERCOAGULABLE STATES BY MEASUREMENT OF ACTIVATION FRAGMENTS AND PEPTIDES
    BOISCLAIR, MD
    IRELAND, H
    LANE, DA
    [J]. BLOOD REVIEWS, 1990, 4 (01) : 25 - 40
  • [9] The inhibitory effect of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, compared with enoxaparin and r-hirudin on ex vivo thrombin generation in human plasma
    Boström, SL
    Hansson, GFH
    Sarich, TC
    Wolzt, M
    [J]. THROMBOSIS RESEARCH, 2004, 113 (01) : 85 - 91
  • [10] Effects of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, and dalteparin on the endogenous thrombin potential in venous blood from healthy male subjects
    Boström, SL
    Hansson, GFH
    Kjaer, M
    Sarich, TC
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (05) : 457 - 462